DNA-Chip Genotyping via Segmented Probe Arrays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA-chips face challenges in simultaneously detecting genetic variations with high sensitivity, specificity, and reproducibility, limiting their application in clinical diagnosis, particularly for conditions like Inflammatory Bowel Disease (IBD), erythrocyte antigens, and adverse reactions to medicine.

Innovation Solution

A method involving DNA-chips with specifically designed oligonucleotide probe pairs and a sequential data processing algorithm that uses hybridization signal intensity to determine genotypes with high accuracy, allowing for the simultaneous, sensitive, specific, and reproducible detection of genetic variations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If DNA-chips are used to detect genetic variations, then large scale studies and high-throughput analysis are enabled, but sensitivity, specificity, and reproducibility are insufficient for clinical diagnosis

Engineering Contradiction:
Improvehigh-throughput analysis capabilityVSAvoiddiagnostic reliability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The chip surface is divided into multiple independent probe regions, each targeting specific genetic variations. This segmentation allows parallel detection of multiple SNPs while maintaining high sensitivity for each individual detection site, resolving the contradiction between high-throughput capability and diagnostic reliability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the chip are designed with locally optimized probe characteristics tailored to specific detection requirements. Each probe region has customized oligonucleotide sequences and concentrations optimized for its target genetic variation, enabling high specificity and sensitivity for each detection site while maintaining overall high-throughput capability.

Inventive Principle:
Principle #3Local quality

2Productivity

If multiple genetic variations are detected simultaneously, then efficiency is improved, but measurement precision and reproducibility deteriorate

Engineering Contradiction:
Improvedetection efficiencyVSAvoidgenotype detection precision
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The detection system is segmented into multiple independent probe regions, each responsible for detecting specific genetic variations. This segmentation enables simultaneous detection of multiple SNPs while maintaining high measurement precision for each individual genotype determination through dedicated optimized probes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The chip employs parameter optimization including adjusted oligonucleotide lengths, concentrations, and sequence compositions for different probe regions. These parameter changes enable simultaneous detection of multiple genetic variations with high precision by tailoring detection conditions to each specific target.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If probe density is increased to enhance detection capability, then sensitivity improves, but manufacturing complexity and cost increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidchip manufacturing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The chip design uses universal probe structures and standardized manufacturing processes that can detect multiple genetic variations. This multi-functionality approach achieves high detection sensitivity through optimized probe density while avoiding excessive manufacturing complexity by using consistent fabrication methods across different detection targets.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables reliable clinical genetic diagnosis by accurately identifying genetic variations associated with IBD, erythrocyte antigens, and adverse reactions, improving diagnostic precision and treatment strategies.

Implementation Method 1

contacting the target DNA with the probes under conditions which allow hybridisation to occur, thereby forming nucleic acid-probe hybridisation complexes

Methodology Applied
Scientific EffectHybridization: Chemical Bonding

Data Source

PatentUS7914990B2Methods and products for in vitro genotyping
Publication Date: 2011.03.29 PROGENIKA BIOPHARMA SA
  • US7914990B2 patent drawing
  • US7914990B2 patent drawing
  • US7914990B2 patent drawing

AI summary

An in vitro method for genotyping genetic variations in a individual, and products for use in the method.